The latest episode of Carte Blanche, airing on March 9, takes a deep dive into a growing health concern affecting millions of women in South Africa.

At the center of the investigation is a commonly used contraceptive injection, administered every three months.

While it has been a trusted method for many, new research has sparked fears about a potential link to serious health risks.

Alarming Study Findings

A recent study suggests a possible connection between this contraceptive and the development of brain tumors.

This revelation has left many women deeply concerned, especially those who have been diagnosed with such conditions.

As the medical community weighs in on these findings, affected individuals are now seeking clarity and answers about the safety of the contraceptive they’ve relied on for years.

Examining the Risks

The episode explores the implications of this potential side effect, scrutinizing the research findings and sharing the experiences of those impacted.

With concerns mounting, it raises critical questions about the long-term safety of this widely used birth control method.

Should women be worried? Is more research needed? The investigation aims to shed light on these pressing issues.

About Carte Blanche

For over 34 years, Carte Blanche has built a reputation as one of South Africa’s most trusted investigative journalism programs.

Since its debut on August 21, 1988, the show has exposed corruption, tackled consumer issues, and covered important current affairs.

Airing every Sunday at 19:00 on M-Net, it continues to bring crucial stories to the public.